Frontage assisted a Sponsor that required accelerated timelines in order to be the first to file a generic anti-epilepsy drug. As a result, the study required a high degree of upfront planning and coordination.
Register to gain access to gated resources.
Thank you for registering!
You now have the option of downloading the resource or viewing the web version below.
Programs that need to include women in their FIH (first in human) studies will find that successful enrollment of women is achievable; however, it requires a concerted effort, with the correct strategies and proper support. In this paper, we explore the challenges in recruiting women for FIH studies and present a set of practices that have proven successful in improving the recruitment rates of women for these studies.
To ensure good data yield, there are challenges encountered during NGS operations, especially with poor quality RNA or DNA material, which is a common scenario for clinical samples. In this poster, we showcase three key tricks during the NGS operations to generate consistent data with high quality.
Please register for a guided virtual tour of Frontage's DMPK facility.